Clinical Trials Browser

shosaiko-to × Clear all

NCT04926545 2024-07-30

XCHT for Irinotecan-Induced Gut Toxicities (Run-in Study)

Phase NA Completed

Diarrhea, Neoplasms

NCT00040898 2013-01-18

Sho-Saiko-To Following Removal of Liver Cancer By Embolization in Treating Patients With Liver Cancer That Cannot Be Surgically Removed

Phase 2 Completed

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms